Skip to content
10-K

Annual Report

SIERRA ONCOLOGY, INC.

0001564590-22-009473

← back to feed
Filed
Mar 10, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Mar 7, 2022 23.67M sh
Capex FY 2021 · Dec 31, 2021 $72K
Capex FY 2021 · Dec 31, 2020 $12K
Capex FY 2021 · Dec 31, 2019 $39K
Operating Cash Flow FY 2021 · Dec 31, 2021 −$78.96M
Operating Cash Flow FY 2021 · Dec 31, 2020 −$52.37M
Operating Cash Flow FY 2021 · Dec 31, 2019 −$51.18M
Cash And Equivalents FY 2021 · Dec 31, 2021 $104.75M
Cash And Equivalents FY 2021 · Dec 31, 2020 $104.06M
Stockholders Equity FY 2021 · Dec 31, 2021 $96M
Stockholders Equity FY 2021 · Dec 31, 2020 $97.96M
Stockholders Equity FY 2021 · Dec 31, 2019 $86.35M
Stockholders Equity FY 2021 · Dec 31, 2018 $94.48M
Current Liabilities FY 2021 · Dec 31, 2021 $12.88M
Current Liabilities FY 2021 · Dec 31, 2020 $9.35M
Total Liabilities FY 2021 · Dec 31, 2021 $13.37M
Total Liabilities FY 2021 · Dec 31, 2020 $9.53M
Current Assets FY 2021 · Dec 31, 2021 $107.39M
Current Assets FY 2021 · Dec 31, 2020 $106.47M
Total Assets FY 2021 · Dec 31, 2021 $109.37M
Total Assets FY 2021 · Dec 31, 2020 $107.49M
Sga Expense FY 2021 · Dec 31, 2021 $27.44M
Sga Expense FY 2021 · Dec 31, 2020 $20.12M
Sga Expense FY 2021 · Dec 31, 2019 $13.74M
Rd Expense FY 2021 · Dec 31, 2021 $67.15M
Rd Expense FY 2021 · Dec 31, 2020 $45.12M
Rd Expense FY 2021 · Dec 31, 2019 $53.25M
Net Income FY 2021 · Dec 31, 2021 −$94.66M
Net Income FY 2021 · Dec 31, 2020 −$80.9M
Net Income FY 2021 · Dec 31, 2019 −$88.28M
Operating Income FY 2021 · Dec 31, 2021 −$94.59M
Operating Income FY 2021 · Dec 31, 2020 −$64.94M
Operating Income FY 2021 · Dec 31, 2019 −$66.99M
Revenue FY 2021 · Dec 31, 2020 $300K